HomeInsightsStock Comparison

Ambalal Sarabhai Enterprises Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Ambalal Sarabhai Enterprises Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: Sep 07, 2025

Key Highlights

  • The Latest Trading Price of Ambalal Sarabhai Enterprises Ltd is ₹ 32.39 as of 05 Sep 15:30.
  • The P/E Ratio of Ambalal Sarabhai Enterprises Ltd changed from 10.4 on March 2020 to 54.8 on March 2025 . This represents a CAGR of 31.91% over 6 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 57.3 on March 2025 . This represents a CAGR of 9.86% over 6 years.
  • The Market Cap of Ambalal Sarabhai Enterprises Ltd changed from ₹ 145.99 crore on March 2020 to ₹ 268.6 crore on March 2025 . This represents a CAGR of 10.70% over 6 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 109468 crore on March 2025 . This represents a CAGR of 21.90% over 6 years.
  • The revenue of Ambalal Sarabhai Enterprises Ltd for the Jun '25 is ₹ 48.7 crore as compare to the Mar '25 revenue of ₹ 66.45 crore. This represent the decline of -26.71% The revenue of Torrent Pharmaceuticals Ltd for the Jun '25 is ₹ 3141 crore as compare to the Mar '25 revenue of ₹ 2941 crore. This represent the growth of 6.8%.
  • The ebitda of Ambalal Sarabhai Enterprises Ltd for the Jun '25 is ₹ 9.82 crore as compare to the Mar '25 ebitda of ₹ -0.07 crore. This represent the decline of -14128% The ebitda of Torrent Pharmaceuticals Ltd for the Jun '25 is ₹ 995 crore as compare to the Mar '25 ebitda of ₹ 922 crore. This represent the growth of 7.92%.
  • The net profit of Ambalal Sarabhai Enterprises Ltd changed from ₹ -4.87 crore to ₹ 8.22 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 548 crore over 9 quarters. This represents a CAGR of 17.95% .
  • The Dividend Payout of Ambalal Sarabhai Enterprises Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 10.76 % on March 2025 . This represents a CAGR of -24.42% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ambalal Sarabhai Enterprises Ltd

  • Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses.
  • Each subsidiary is a distinct entity contributing its unique expertise and capabilities.
  • It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally.
  • ASE's strength is to lead with cutting edge technology by creating strategic technology tie-ups and collaborative partnerships through our broad national and international networks The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments.
  • It operates in two segments, pharmaceuticals and electronics.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

Ambalal Sarabhai Enterprises Ltd News Hub

News

Ambalal Sarabhai Enterprises to announce Quarterly Result

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

05 Aug 2025 15:06

News

Ambalal Sarabhai Enterprises schedules AGM

Ambalal Sarabhai Enterprises announced that the 47th Annual General Meeting(AGM) of the co...

Read more

07 Jun 2025 09:30

News

Ambalal Sarabhai Enterprises to table results

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

23 May 2025 17:45

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

06 Feb 2025 11:55

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

05 Nov 2024 13:38

News

Ambalal Sarabhai Enterprises announces board meeting date

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

03 Aug 2024 10:31

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharma's Vizag facility clears USFDA inspection with zero observations

According to an exchange filing, the inspection was conducted from 28 July to 1 August 202...

Read more

04 Aug 2025 09:44

News

Torrent Pharma gains as Q1 earnings impress; foreign broker hikes target

The pharma major reported a net profit of Rs 548 crore, marking a 20% year-on-year increas...

Read more

29 Jul 2025 10:36

News

Torrent Pharmaceuticals Ltd gains for third straight session

Torrent Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting...

Read more

29 Jul 2025 13:05

News

Board of Torrent Pharmaceuticals approves issuance of NCDs/ bonds

The Board of Torrent Pharmaceuticals at its meeting held on 28 July 2025 has approved the ...

Read more

28 Jul 2025 16:32

News

Torrent Pharmaceuticals to hold board meeting

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28...

Read more

22 Jul 2025 10:21

News

Torrent Pharmaceuticals Ltd gains for fifth session

Torrent Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quot...

Read more

18 Jul 2025 13:00

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Ambalal Sarabhai Enterprises Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Ambalal Sarabhai Enterprises Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ambalal Sarabhai Enterprises Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Ambalal Sarabhai Enterprises Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Ambalal Sarabhai Enterprises Ltd is 248 Cr while Market cap of Torrent Pharmaceuticals Ltd is 121,156 Cr

What are the key factors driving the stock performance of Ambalal Sarabhai Enterprises Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Ambalal Sarabhai Enterprises Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ambalal Sarabhai Enterprises Ltd and Torrent Pharmaceuticals Ltd?

As of September 7, 2025, the Ambalal Sarabhai Enterprises Ltd stock price is INR ₹32.39. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3579.95.

How do dividend payouts of Ambalal Sarabhai Enterprises Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Ambalal Sarabhai Enterprises Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions